Apoptosis mechanism of human cholangiocarcinoma cells induced by bile extract from crocodile

Applied Biochemistry and Biotechnology

Volumn 166, Issue 4, 2012, Pages 942-951

  Kang, Jin He ^a   Zhang, Wen Qing ^a   Song, Wei ^a   Shen, Dong Yan ^a   Li, Shan Shan ^a   Tian, Ling ^a   Shi, Yan ^a   Liang, Ge ^a   Xiong, You Xiong ^b   Chen, Qing Xi ^a  

^a XIAMEN UNIVERSITY   (China)

^b Sriracha Tiger Zoo Co Ltd   (Thailand)

Author keywords

Apoptosis; Bcl 2; Bile; Crocodile; Cytochrome c; QBC939 cells

Indexed keywords

BCL-2; BILE; BILE ACID; CELL APOPTOSIS; CELL CYCLE; CHOLANGIOCARCINOMA; CROCODILE; CYTOCHROME C; CYTOSOLS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PATHWAYS; MTT ASSAYS; TRANSMISSION ELECTRON MICROSCOPY (TEM); WESTERN BLOTTING;

CELL DEATH; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MITOCHONDRIA; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

BODY FLUIDS;

ANTINEOPLASTIC AGENT; BILE EXTRACT; CASPASE 3; CROCODILE BILE EXTRACT; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ALLIGATOR; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CARCINOMA CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENZYME RELEASE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GALLBLADDER; HUMAN; HUMAN CELL; MICROSCOPY; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ALLIGATORS AND CROCODILES; ANIMALS; APOPTOSIS; BILE; BILE DUCT NEOPLASMS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CHOLANGIOCARCINOMA; COMPLEX MIXTURES; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE; GENE EXPRESSION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84858751544     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-011-9482-x     Document Type: Article

References (21)

1. Mahmoud, N. N., Dannenberg, A. J., Bilinski, R. T., Mestre, J. R., Chadburn, A., Churchill, M., et al. (1999). Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis, 20, 299-303. doi:10.1093/carcin/20.2.299. (Pubitemid 29057564)
2. Martinez, J. D., Stratagoules, E. D., LaRue, J. M., Powell, A. A., Gause, P. R., Craven, M. T., et al. (1998). Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutrition and Cancer, 31, 111-118. doi:10.1080/01635589809514689. (Pubitemid 28428071)
3. Tatsumura, T., Sato, H., Yamamoto, K., & Ueyama, T. (1981). Ursodeoxycholic acid prevents gastrointestinal disorders caused by anticancer drugs. The Japanese Journal of Surgery, 11, 84-89. doi:10.1007/ BF02468874.
4. Alberts, D. S., Martinez, M. E., Hess, L. M., Einspahr, J. G., Green, S. B., Bhattacharyya, A. K., et al. (2005). Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. Journal of the National Cancer Institute, 97, 846-853. doi:10.1093/jnci/dji144. (Pubitemid 40909127)
5. Tint, G. S., Dayal, B., Batta, A. K., Shefer, S., Joanen, T., Larry, M., et al. (1980). Biliary bile acids, bile alcohols, and sterols of Alligator mississippiensis. Journal of Lipid Research, 21, 110-117.
6. Yeh, Y. H., Wang, D. Y., Liau, M. Y., Wu, M. L., Deng, J. F., Noguchia, T., et al. (2003). Bile acid composition in snake bile juice and toxicity of snake bile acids to rats. Comparative Biochemistry and Physiology, 136, 277-284. doi:10.1016/S1532-0458(03)00230-8.
7. Malhi, H., & Gores, G. J. (2006). Cholangiocarcinoma: Modern advances in understanding a deadly old disease. Journal of Hepatology, 45, 856-867. doi:10.1016/j.jhep.2006.09.001. (Pubitemid 44646688)
8. Patel, T. (2002). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2, 10. doi:10.1186/1471-2407-2-10.
9. Lazaridis, K. N., & Gores, G. J. (2005). Cholangiocarcinoma. Gastroenterology, 128, 1655-1667. doi:10.1053/j.gastro.2005.03.040. (Pubitemid 40692558)
10. Gatto, M., Bragazzi, M. C., Semeraro, R., Napoli, C., Gentile, R., Torrice, A., et al. (2010). Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease, 42, 253-260. doi:10.1016/j. dld.2009.12.008.
11. Hu, Y., Yang, Y., You, Q. D., Liu, W., Gu, H. Y., Zhao, L., et al. (2006). Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. Biochemical and Biophysical Research Communications, 351, 521-527. doi:10.1016/j.bbrc.2006.10.064. (Pubitemid 44666718)
12. Han, P., Kang, J. H., Li, H. L., Hu, S. X., Lian, H. H., Qiu, P. P., et al. (2009). Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression. Biochemical and Biophysical Research Communications, 385, 251-256. doi:10.1016/j. bbrc.2009.05.059.
13. Farnebo, M., Bykov, V. J., & Wiman, K. G. (2010). The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer. Biochemical and Biophysical Research Communications, 396, 85-89. doi:10.1016/j.bbrc.2010.02.152.
14. Mork, C. N., Faller, D. V., & Spanjaard, R. A. (2005). A mechanistic approach to anticancer therapy: Targeting the cell cycle with histone deacetylase inhibitors. Current Pharmaceutical Design, 11, 1091-1104. doi:10.2174/1381612053507567. (Pubitemid 40403370)
15. Tompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462. doi:10.1126/science.7878464.
16. Green, D. R. (1998). Apoptotic pathways: The roads to run. Cell, 94, 695-698.
17. Green, D. R., & Reed, J. C. (1998). Mitochondria and apoptosis. Science, 281, 1308-1312. doi:10.1126/ science.281.5381.1309.
18. Zong, W. X., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q. C., Yuan, J., et al. (2003). Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. The Journal of Cell Biology, 162, 59-69. doi:10.1083/jcb.200302084. (Pubitemid 36859535)
19. Circu, M. L., & Aw, T. Y. (2010). Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology & Medicine, 48, 749-762. doi:10.1016/j.freeradbiomed.2009.12.022.
20. Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., et al. (2003). NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. The EMBO Journal, 22, 3898-3909. doi:10.1093/emboj/cdg379. (Pubitemid 36975716)
21. Chen, Y., & Gibson, S. B. (2008). Is mitochondrial generation of reactive oxygen species a trigger for autophagy? Autophagy, 16, 246-248. (Pubitemid 351231192)